|
HS Code |
750705 |
| Chemical Name | 3,4-Dichlorobenzyl Bromide |
| Cas Number | 4616-84-6 |
| Molecular Formula | C7H5BrCl2 |
| Molecular Weight | 239.93 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 55-58°C |
| Boiling Point | 150°C at 12 mmHg |
| Density | 1.682 g/cm³ |
| Solubility | Insoluble in water, soluble in organic solvents |
| Purity | Typically ≥98% |
| Storage Conditions | Store in a cool, dry place; keep container tightly closed |
As an accredited 3,4-Dichlorobenzyl Bromide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle, sealed cap, hazard labels, contains 25 grams of 3,4-Dichlorobenzyl Bromide; includes safety and handling instructions. |
| Shipping | 3,4-Dichlorobenzyl Bromide is shipped in tightly sealed containers, typically made of glass or compatible plastic, to prevent leakage and contamination. It is classified as a hazardous material; therefore, all packaging must comply with local and international transport regulations for corrosive and toxic substances, including appropriate labeling and safety documentation. |
| Storage | **3,4-Dichlorobenzyl Bromide** should be stored in a tightly sealed container, away from light and incompatible substances such as strong oxidizers, acids, and bases. Keep it in a cool, dry, well-ventilated area, preferably in a chemical fume hood. Ensure that the storage area is clearly labeled and access is restricted to trained personnel. Use appropriate secondary containment to prevent spills. |
Applications of 3,4-Dichlorobenzyl Bromide in Industrial Manufacturing3,4-Dichlorobenzyl Bromide serves as a key specialty intermediate across several downstream industrial production domains. Our proprietary synthesis technology ensures lot-to-lot consistency and traceable supply for each tailored end-use pathway. 1. Active Pharmaceutical Ingredient (API) SynthesisAPI manufacturers use our 3,4-Dichlorobenzyl Bromide in the synthesis of select antihypertensive and antifungal actives, including cationic intermediates that require precise halogenation. The compound participates in stepwise alkylation or bromination reactions during the construction of advanced pharmaceutical intermediates. Tight impurity profiles and strict control in each batch guarantee compliance with regulatory drug master file (DMF) specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate ProductionFormulators in the crop protection sector employ 3,4-Dichlorobenzyl Bromide as an alkyl chloride building block for synthesizing advanced herbicide and fungicide molecules. Reaction pathways include nucleophilic substitution and coupling with heterocyclic precursors, enabling production of specific actives with targeted selectivity for major agricultural markets. We ensure residue and impurity control meets downstream formulation benchmarks. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Polymer Additives ManufacturingSpecialty polymer manufacturers use our material as a halogen source in the production of flame retardant compounds for engineering plastics. The benzyl bromide structure enables covalent bonding in melt-phase copolymerization or surface modification. Chlorinated aromatic intermediates deliver performance in high-temperature polymer systems, including those used in wire insulation and electronics casings. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Synthesis for Dyes & PigmentsFine chemical producers integrate our 3,4-Dichlorobenzyl Bromide in the preparation of azo and anthraquinone dye intermediates. The compound serves as a bromine donor and ring-activation agent, enhancing color fastness and resistance in pigments for textile, leather, and plastics applications. Proprietary precipitation and purification processes ensure product compatibility with major dye formulation systems. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Chemical Research and Custom SynthesisCROs (contract research organizations) and industrial R&D teams rely on our material for multistep custom synthesis projects, including structure-activity relationship studies and new molecule discovery. Its dual halogenation enables synthesis of unique heterocyclic and aromatic derivatives for specialty applications in high-value sectors. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3,4-Dichlorobenzyl Bromide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Nearly two decades ago, our facility took on the challenge of enhancing aromatic bromides, and the journey with 3,4-Dichlorobenzyl Bromide stands out as one of the most demanding and rewarding. In chemical manufacturing, precise halogenation becomes crucial for producing intermediates with both selectivity and reliability. 3,4-Dichlorobenzyl Bromide, featuring the dichloro substitution on the benzyl ring and a reactive bromomethyl group, represents a cornerstone for specialty organic synthesis.
Our years spent in the plant, refining each batch, have made it clear: every minor improvement in purity leads to significant advances in downstream reaction control. The compounds made possible by this molecule find essential roles in crop protection, advanced materials, and pharmaceutical work. It is not an exaggeration to say that a single incremental rise in assay makes a difference in high-value products.
The process for making 3,4-Dichlorobenzyl Bromide is simple only on paper. We work with carefully vetted 3,4-dichlorotoluene, controlling every parameter from bromination rate to reaction temperature. Liquid bromine remains a challenge, and the handling protocols have evolved based on hard lessons. Every reactor batch finds its quality put through GC and NMR, looking for not just the headline numbers but also minor byproducts that could trip up clients' syntheses.
While scale brings some advantages, we keep lines small enough to spot irregularities. Some customers might accept a 95% spec, but our plant rarely ships below 98% by HPLC. Moisture content and residual halide stick out as concerns, and drying lines and careful final filtration have become routines rather than afterthoughts. Through lots of trial and error, we’ve optimized agitation to manage crystallization and avoid clogging—a problem that used to cost the team hours in midwinter runs.
We do not chase flashy model numbers, but consistency in molecular weight, melting point, and density creates the genuine difference. In our experience, the 3,4-dichloro arrangement gears the molecule for selectivity: ortho and para positions matter when tuning for specific biocidal or functional properties.
Our 3,4-Dichlorobenzyl Bromide arrives in white to pale yellow crystalline form. Our best batches yield material with minimal oiling out and sharp crystalline structure. Packing gets handled in sealed, light-blocking drums, since we found early on that UV impacts stability over transport. GC analysis after extended overseas shipping convinced us to add a nitrogen flush on export lots. Customers consistently remark on ease of handling—flowability matters even in a moisture-controlled lab.
Melting point holds steady between 61-65 °C in plants running at standard pressure. This matters particularly for users in formulation development who need thermal consistency to avoid variability in downstream processing. For those blending the material in organic synthesis, solubility in common polar aprotic solvents—especially DMF and DMSO—lets us vouch for repeatable results in nucleophilic substitution applications.
This compound rarely appears in finished consumer products. Its true advantages reveal themselves as an intermediate, where selectivity and reactivity matter above all. Several clients in agrochemical R&D need the dichloro orientation to develop actives with potent, selective action. Fine chemical makers often tell us that, compared to similar benzyl bromides, this version gives more reliable yields in ether or amine formation.
As a key building block for pharmaceuticals, its bromomethyl group reacts efficiently with nucleophiles, saving steps in multi-stage syntheses. The dichloro groups offer metabolic persistence, making the product valuable for API makers seeking robust starting points. Over the years, more than one major project has been salvaged just by moving from mono-chloro to our 3,4-dichloro variant.
Materials scientists, developing specialty polymers, report that the dichloro substitution adds both chemical resistance and the kind of rigidity needed for thermal management applications. For example, several polyurethane producers have shifted to our compound for making high-performance crosslinkers, citing both reactivity and better isolation in purification runs.
It’s tempting to see all benzyl bromides as interchangeable, but years in a plant teach a different lesson. The dichloro arrangement in the 3 and 4 positions resists some common breakdown pathways. Chemists working with mono-chloro, ortho, or para analogs often report more side reactions, especially chlorination at unintended sites. Side-by-side runs in lab glassware, then in pilot reactors, have shown that switching to the 3,4-dichloro structure sharply reduces formation of benzyl alcohols as byproducts.
While other brominated benzylic agents need stabilizers or prompt refrigeration, our 3,4-Dichlorobenzyl Bromide, as produced and packed, stands up better to cross-continental shipping. Natural resistance to oxidative breakdown means it generally arrives ready for use, without off odors or loss of reactivity.
Some manufacturers take shortcuts by running mass bromination in hastily vented kettles, creating products with yellow-brown shading and higher residue. Our line always bleeds off excess bromine and checks for color values on every drum. Years ago, we took in samples from a new supplier—intended as a cost save—and saw, by TLC and GC, that contamination from polybrominated byproducts gave inconsistent results in final reactions. Since then, we never dilute on quality, favoring clarity and sharp melting range over raw output numbers.
Many buyers switching from unsubstituted benzyl bromides tell us they see less unwanted alkylation when running with our grade. Those working in the API field especially value the increased selectivity and lower environmental load in waste disposal resulting from fewer chlorinated tars.
As global supply chains tighten and regulatory pressures rise, backward integration into raw materials gives our plant an advantage. Relying on stable relationships with chlorotoluene producers lets us skirt price shocks and quality surprises. Environmental requirements now demand more energy recovery and better halogen waste capture, so the team has invested in condensers, high-efficiency scrubbers, and secondary containment. Instead of fighting process bottlenecks, the focus sits on boosting batch yield and capture at the source.
Many specifiers now ask about traceability and green chemistry. Over the past five years, we replaced older chlorination lines with higher-yield, closed-circuit reactors. Production waste dropped by over 20%. Bromine recovery rates in spent acid are tracked daily, and we maintain full batch genealogy records for every drum. Committing to this step cost more in the short term, but saved major headaches—and unexpected rejections—from downstream processors, especially in Europe and Japan. Our approach to documentation, once seen as overkill, now turns into real contract advantage.
From collaboration comes progress. Several pharmaceutical labs have shared data on their preferred nucleophilic displacement conditions, enabling us to adjust product moisture targets and reduce delays on their side. In turn, our partners pick up small, trusted lots well in advance of scale-up, tuning their reactions before committing to full runs. We serve not just as a supplier but as a sounding board for tweaks and troubleshooting—seeing our product through to successful downstream chemistry shapes how we view continuous improvement.
Investing in manufacturing precision pays off both for us and for the end customer. After a series of winter batches where crystal habit changed and jarred filling lines, we fine-tuned both solvent composition and temperature gradients. The result: sharper melting curves and lower dust formation, important for labs running semi-automated equipment that hates powders. On export, each lot goes through a stability protocol informed by real complaints and transport studies. When a drum fell short in Brazil due to seal failure, we changed cap designs across the board.
We see feedback loops with customers not as a burden, but as the main driver behind small but vital upgrades. Years ago, a client in industrial coatings found black specs in a batch; afterward, visual particle checks joined standard release criteria. Repeat business tells its own story: clients return not merely for a label, but for dependability over years of seasonal and regulatory changes.
The market for halogenated intermediates remains fiercely competitive. We build our approach on direct connection from chemist to plant operator, with regular cross-team reviews on both sides. No satellite offices or distant contract blenders dilute responsibility. When a batch leaves our facility, it has seen oversight from order intake to final drum check—the same approach followed since our earliest runs.
Most improvements that matter do not spring from internal brainstorming. Joint troubleshooting with users—sometimes at their own sites—has highlighted both opportunities and pitfalls. A specialty pharma client once reported inconsistencies in alkylation efficiency for a key step. Our technical team responded with in-process GC testing, correlating results with slight changes in crystal morphology. The fix was not obvious: subtle adjustments in drying cycles solved what looked like an unrelated purification issue. Sustained calls, not just emails, make sure their scientists feel confident running large-scale prep with our material.
Every major client project brings new data. Some label variability under trace limits as irrelevant, but our plant views the application as king. What helps a polymerizer can hinder a pharma intermediate; we do not batch-blend for ‘average’ needs. Close dialog on end-use lets formulation chemists weigh in before final drum filling. Often, those with the strictest needs produce the most valuable improvements. Quality claims find fast resolution because decision-makers remain hands-on and accessible. This is not just a claim but a cultural principle carried through all aspects of our work.
Compliance with evolving regulations acts not as a box-ticking exercise, but as a foundation for sustainable operations. As jurisdictions update lists of controlled organohalogens, our regulatory and technical teams keep pace, monitoring shifts in allowable thresholds. No export batch leaves without full documentation, including assay, identity, and impurity profiles that exceed minimum requirements.
Responsible manufacturing in today’s world means not just safe product, but responsible waste and emissions handling. Our site gardens its own effluent, treating brominated streams on site and adhering closely to both national and international disposal guidelines—something not all competitors can claim with confidence. Customers have direct access to documentation proving both batch pedigree and process compliance, giving peace of mind against audit or regulatory scrutiny.
Frequent site and process audits by external partners have pushed us toward ever tighter quality standards. Newer engineers and operators learn to spot both visual and instrumental indications of off-spec lots, and get empowered to call for reprocessing if needed, not just for premium contracts but all orders. Such practices save hassle and litigation down the line, and protect both partner reputation and our own.
Our journey with 3,4-Dichlorobenzyl Bromide is not just about filling tonnage orders, but about being part of thousands of other breakthroughs. Early days involved plenty of chemistry by trial and plenty of error: before in-line GC and real-time data, minor purity drops escaped attention. Now vigilance extends from raw stock review to real-time sensor feedback. This vigilance gets reflected not only in audit records, but in the consistency our customers count on.
Markets shift as technologies do. We see a steady rise in specialized applications—biologically oriented molecules, advanced polymer systems, and defensive chemistry in agriculture. Each brings demands for ever-clearer impurity profiles, tailored particle size, and storage protocols. The real challenge lies in blending flexibility for niche needs with the rock-solid dependability required by core customers. Our company remains committed to this challenge and welcomes honest, detailed feedback from every downstream user.
The story of 3,4-Dichlorobenzyl Bromide in our facility is one of wresting predictability out of a process that resists shortcuts. It’s a task requiring not just good chemistry, but persistence, curiosity, and a direct channel to those who rely on this compound’s stability, selectivity, and performance. Years of real-world testing and close partnerships have taught us that quality comes from attention to small details, willingness to learn from setbacks, and a relentless focus on what matters most in the hands of the chemists, engineers, and scientists we aim to serve.